| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |